Trial Profile
Efficacy of steroid and nonsteroidal anti-inflammatory eye drops in management of post-operative inflammation and prevention of pseudophakic cystic macular
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Nepafenac (Primary) ; Prednisolone acetate (Primary)
- Indications Ocular inflammation; Retinal oedema
- Focus Therapeutic Use
- 26 Nov 2015 New trial record